San Jose Convention Center
San Jose, CA
Wilson Sonsini is proud to sponsor SynBioBeta 2025: The Global Synthetic Biology Conference, where biology becomes the blueprint and human innovation, the artisan. Attend this event for an unparalleled four-day summit delving into synthetic biology.
On Tuesday, May 6th at 4:30 pm partner Ian Edvalson will moderate the panel session, Future of the U.S. Bioeconomy, with panelists Carrie Wolinetz, Government Relations at Lewis-Burke Associates LLC; Sarah Carter, Principal at Science Policy Consulting; Kerri Dugan from TIP Emerging Technologies, at the National Science Foundation; and Sylvia Wulf, Interim EVP at Biotechnology Innovation Organization (BIO).
On Thursday, May 8th at 1:30 pm partner Maya Skubatch will moderate the panel session, SynBio Solutions: Fast-Tracking Vaccines and Personalized Medicine for Global Health, with panelists Jacob Glanville, Founder, CEO & Chairman of Centivax; Brian Parker, Head of Bioinformatics at BreakBio; Maurizio Zanetti, UCSD Cancer Center; Clare Lou, CEO & Co-Founder at Sift Biosciences; and Bernie Fox, Co-Founder and CEO of UbiVac.
On Thursday, May 8th at 2:30 pm partner Maya Skubatch will moderate the panel session, Deconstructing Cellular Diversity: Single-Cell Sequencing for Drug Discovery and Synthetic Biology. Fellow panelists include Alex Rosenberg, CEO at Parse Biosciences; Rob Tarbox, VP of Product Marketing at Complete Genomics; Xi Chen, Founder of RootPath Genomics, and Nima Alidoust, CEO & Co-Founder, at Vevo Therapeutics.
At the conference, learn why the costs of reading, writing, and editing DNA plummet while speed and accessibility soar. Gain insights into cutting-edge medical advancements such as cell therapies, vaccines, and living medicines. Discover how companies harness biology to produce bio-based jet fuel, textiles, concrete, and other chemicals and materials. Engage with trailblazing entrepreneurs crafting innovative foods, crops, and fragrances. Join us to see the potential applications of these technologies in shaping sustainable manufacturing ecosystems.
Katie Stonum
kstonum@wsgr.com
Maya Skubatch was a partner in the Palo Alto office of Wilson Sonsini Goodrich & Rosati and a former member of the firm’s board of directors. Maya focused on strategic patent counseling for both private and public life science companies. She worked closely with licensing, litigation, corporate, and regulatory counsel to provide integrated IP strategies and often assists clients with intellectual property matters pertaining to financings, M&A, and partnership deals. Maya also worked with investors on IP diligence matters.